Novo CEO pressed by Senate to cut charges of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would consider new talks with insurers in regards to the record costs of Wegovy and copyright whenever they pledge to maintain the medicines on their formularies. This prepare aligns with https://arizonahardnutritionfacts16161.blogs-service.com/61637431/the-smart-trick-of-healthcare-news-that-nobody-is-discussing